[es] US health agency unveils weight-loss drug coverage model

[es] [Agent Verified] The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D plans, following the Trump administration's price-cut deal.